
BioAlert
Continuous monitoring technology for Legionella pneumophila bacteria.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
* | N/A | Support Program | |
Total Funding | 000k |
Related Content
BioAlert specializes in the development and deployment of automated, on-site Legionella monitoring systems designed for continuous surveillance of water quality in cooling towers and other water systems. Their technology eliminates the need for manual sampling by integrating directly into the cooling system infrastructure, where it performs all tests and sampling automatically. Results are delivered in less than four hours, enabling daily analysis and rapid response to any detected Legionella presence. The system is complemented by a remote-controlled digital platform, allowing facility managers and operators to activate water analyses and monitor test results from any location, thus ensuring ongoing compliance and safety without the need for on-site human intervention. By leveraging IoT and sensor technologies, BioAlert addresses critical health and regulatory concerns associated with Legionella outbreaks, providing a robust solution for organizations tasked with maintaining water safety standards. Their offering is particularly relevant for industries where waterborne pathogens pose operational and health risks, such as building management, healthcare, and industrial operations. Through its innovative approach, BioAlert supports public health goals and regulatory compliance, contributing to safer environments and more efficient facility management